Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites

Velocity Clinical Research, the leading multi-specialty clinical sites business, and Privia Health, a physician enablement company serving more than 3,700 providers and 4.4 million patients, today announced a partnership to open embedded clinical research sites within Privia’s practice network. The partnership is intended to establish integrated research sites within existing Privia Care Center locations that […]

Promising Future For The Global CRO Market With 8.4% CAGR

As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is expected to CAGR (experience a compound annual growth rate) of 8.4 percent between 2023 and 2033. However, the CRO market may face challenges due to non-uniform regulations across different governments, which […]

Germany – Saudi Arabia Tie – Up To Boost Rare Disease Testing

Centogene, a life science company based in Germany that specializes in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company owned by the Public Investment Fund (PIF), have joined forces in a strategic collaboration. They have formed a Joint Venture (JV) with the aim of enhancing local and regional availability and expedited delivery of top-notch […]

Japan To Make Its Preparedness & Response To Pandemic Robust

The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have gone on to sign a Memorandum of Cooperation- MoC so as to strengthen the partnership between both organisations as they look forward to speeding up global preparedness as well as response […]

Expansion of Biomedical Research On The Cards In Australia

Monash University- Australia has gone on to buy a prominent Parkville property that will go on to become a major addition to its campus, which is home to the world-leading Faculty of Pharmacy and Pharmaceutical Sciences, and thereby unprecedentedly advance the capabilities of Australia’s biomedical research so as to drive the discovery as well as […]

Pharmaceutical Products Take Center Stage In US – China Trade

The US-China trade in pharmaceuticals has shifted due to the trade war and the pandemic. While some sectors have seen a decline, pharmaceutical trade between the two countries has grown. Pharmaceutical products now make up nearly 3% of the total trading relationship, driven by advanced medicines. The trade is balanced, with the US importing $10.2B […]

China Remains An Attractive Market For Pharma Investment

A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an appealing market for investment. AstraZeneca defies geopolitics to bet on China – Financial Times (paywalled) AstraZeneca’s CEO expressed his excitement about the surge of biotech companies in China and the potential […]

From Decline To Rebound: Biotech M&A Expected To Bounce Back

2022 was an unremarkable year for biotech mergers and acquisitions (M&A) as the industry experienced a decline in both the number and value of deals. This was mainly due to economic and geopolitical uncertainties, causing potential buyers to exercise caution. According to insights, the total value of all M&A transactions signed in 2022 dropped significantly […]

Ardena and RiboPro Forge Strategic Alliance to Support the RNA Revolution with End-to-End Manufacturing of Advanced mRNA and LNP Solutions

Leading contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering improvements to the global availability of RNA-based health treatments and address a crucial skills gap in the industry. The new alliance combines Ardena’s expertise in custom development and cGMP manufacturing of […]

Pharma Targeting Launch Partner Identifier to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients

Pharma Targeting, part of the The Targeting Group and a leading global pharmaceutical market intelligence and data company, has unveiled its latest pioneering initiative, designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. The service uses data-driven intelligence to help customers identify and engage […]